Company
Encore Vision
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
is a clinical-stage subsidiary of Novartis that is developing novel small molecule therapies for the topical treatment of presbyopia, a condition of worsening vision due to aging.
Loading relationship preview